Industry News

Cipla Ltd, India's fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc's generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission,..."/>
Cipla, Aurobindo Pharma acquire products divested by Teva in US [Mint, New Delhi]
Aurinia Pharmaceuticals Inc. today announced it will host a Lupus Nephritis expert breakfast on Thursday, August 4th from 8:00am to 9:30am EDT in New York. The topics of the presentations will include current treatments for Lupus Nephritis, its disease burden, as well as pharmacoeconomic and pricing dynamics for new products for less common diseases in the US market place. The company will also take this opportunity to review in further detail the..."/>
Aurinia Pharmaceuticals to Host Lupus Nephritis Expert Breakfast and Webcast on August 4th in New York
PRA Health Sciences-- both contract research organizations headquartered in Raleigh-- delivered strong second-quarter results that featured double-digit revenue growth that exceeded analysts' expectations. Shares of INC, which reported its results before the markets opened Thursday, closed at $44.97, up 3 percent. PRA Health Sciences issued its second-quarter numbers after the markets closed."/>
INC Research and PRA Health Sciences post double-digit revenue growth [The News & Observer (Raleigh, N.C.)]
Natera, Inc., a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced that it will release results for its second quarter ended June 30, 2016 after the market close on August 4, 2016. Natera will host a conference call and webcast at 1:30 p.m. PT to discuss its financial results, business activities and financial outlook. Natera is a genetic testing company that develops and..."/>
Natera Announces Second Quarter Earnings Conference Call
M and A Navigator: Deal pipeline –28 July
AbbVie, a global biopharmaceutical company, today announced the initiation of a Phase 3 clinical trial to study the safety and efficacy of venetoclax in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma who are considered sensitive or naïve to proteasome inhibitors and have received one to three prior lines of therapy. The combination of venetoclax, bortezomib and..."/>
AbbVie Announces Initiation of Phase 3 Study of Venetoclax in Patients with Relapsed or Refractory Multiple Myeloma
Cigna may not move forward as quickly as Anthem officials hoped. The DOJ filed a lawsuit last night to block the proposed $54 billion acquisition, stating the deal could have a negative impact on consumers."/>
U.S. Government: Anthem's Closing Deadline Not A Good Reason To Rush To Trial [The Hartford Courant]
Valeant Pharmaceuticals International, Inc. today announced that the Board of Directors has appointed Ms. Sarah B. Kavanagh to serve as a director of the Board, effective July 22, 2016. With these changes, Valeant has increased the size of its board to 12 members, 11 of whom are independent."/>
Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors
Kindred Healthcare, Inc. today announced that it has signed a definitive agreement with CHI Franciscan Health to create a joint venture to construct and operate a 60- bed inpatient rehabilitation hospital in Tacoma, Washington, which is located in Kindred’ s Seattle integrated care market. The project recently received Certificate of Need approval from the..."/>
Kindred Healthcare and CHI Franciscan Health Announce Plans for Inpatient Rehabilitation Hospital
Zecotek Photonics Inc., a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the major medical OEM based in China, which selected Zecotek's patented lutetium fine silicate scintillation crystals for a new line of high resolution positron emission tomography medical imaging devices, has assembled the first PET medical scanner for testing and has ordered..."/>
Chinese OEM Successfully Assembles First Positron Emission Tomography Medical Scanner and Orders LFS Scintillation Crystals for Second Unit
Valeant Pharmaceuticals International, Inc. today announced that the Board of Directors has appointed Ms. Sarah B. Kavanagh to serve as a director of the Board, effective July 22, 2016. With these changes, Valeant has increased the size of its board to 12 members, 11 of whom are independent. "We are pleased that Sarah has agreed to join Valeant's board," said Joseph C. Papa, chairman and chief executive officer. ""/>
Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors
Zecotek Photonics Inc., a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the major medical OEM based in China, which selected Zecotek's patented lutetium fine silicate scintillation crystals for a new line of high resolution positron emission tomography medical imaging devices, has assembled the first PET medical scanner for testing and has ordered Zecotek`s..."/>
Chinese OEM Successfully Assembles First Positron Emission Tomography Medical Scanner and Orders LFS Scintillation Crystals for Second Unit
Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2016.. Total revenues of $17.1 million in the second quarter of 2016, an increase of 93% over the same quarter in 2015. Total net revenues generated from the sale of our generic topical and injectable pharmaceutical products for the three months ended June 30, 2016 and 2015 of $11.1 million..."/>
Teligent, Inc. Announces Second Quarter 2016 Results
Sequenom, Inc. in a cash tender offer of USD 2.40 per share, or an equity value of USD 302 m, the company said. The price represents a total enterprise value of approximately USD 371 m, including net indebtedness. Under the terms of the agreement and plan of merger, LabCorp has formed an acquisition subsidiary, Savoy..."/>
LabCorp Agrees to Acquire Genone Interpretation Specialist Sequenom in USD 302m Deal
American Renal Associates, Inc. violated applicable laws by causing the company to engage in health insurance fraud. American Renal Associates operates as a dialysis services provider in the United States focused exclusively on joint venture partnerships with physicians. View this press release on the law firm's Shareholder Rights Blog:..."/>
Robbins Arroyo LLP Is Investigating the Officers and Directors of American Renal Associates Holdings, Inc. (ARA) on Behalf of Shareholders
China Cord Blood Corporation, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual Report on Form 20- F with the U.S. The filed Form 20- F includes audited financial statements for the fiscal year ended March 31, 2016. The Form 20- F can be accessed by visiting the U.S."/>
China Cord Blood Corporation Files Its Annual Report on Form 20-F
Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the 36 th Annual Canaccord Genuity Growth Conference, to be held at the InterContinental Boston hotel in Boston, Massachusetts on Wednesday, August 10, 2016.. Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will present that day at..."/>
Quidel to Present at the 36th Annual Canaccord Genuity Growth Conference
Mallinckrodt plc, a leading global specialty pharmaceutical company, today confirmed enrollment of the first patient in the company's Phase 3 clinical study to evaluate the efficacy and safety of terlipressin in subjects with Hepatorenal Syndrome type 1.. "Patients diagnosed with HRS type 1 typically have a very poor prognosis, and there is a significant unmet need for an approved treatment," said lead investigator..."/>
First Patient Enrolled in Mallinckrodt Phase 3 Terlipressin Trial
Otonomy, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced it will report financial results for the second quarter 2016 as well as provide a corporate update at 4:30 p.m. EDT on August 4, 2016.. The live call may be accessed by dialing 305-6769 for domestic callers and 562-4239 for international callers with conference ID code number:..."/>
Otonomy to Report Second Quarter 2016 Financial Results and Provide Corporate Update
HealthSouth Corporation, one of the nation's largest providers of post-acute healthcare services, offering both facility-based and home-based post-acute services, today reported its results of operations for the second quarter ended June 30, 2016.. "The second quarter was another strong quarter for HealthSouth with volume, revenue, and earnings from our recent acquisitions complementing solid organic growth," said Jay Grinney,..."/>
HealthSouth Reports Strong Revenue, Volume, and Earnings Growth for Second Quarter 2016 and Raises Full-Year 2016 Guidance
Focus on filgotinib and cystic fibrosis
Quality Systems, Inc. announced today results for its fiscal 2017 first quarter ended June 30, 2016.. “In the first quarter, we saw a number of positive developments as we continued to execute on our strategic plan and have made great progress reinvigorating the culture of our organization,” commented Rusty Frantz, president and chief executive officer of Quality Systems, Inc.“ In addition, we remain focused on our solutions integration and product roadmap..."/>
Quality Systems, Inc. Reports Fiscal 2017 First Quarter Results
BD Names R. Andrew Eckert To Board Of Directors

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Information Technology855 Articles
Financials846 Articles
Consumer Discretionary724 Articles
Industrials549 Articles
Health Care530 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.